CTSK and carcinoma: large sized carcinomas (T3 and T4) showed mainly strong (19 cases, 73.1%) and moderate (4 cases, 15.4%) expression, while small-sized carcinomas (T1 and T2) showed negative (7 cases, 36.8%) and weak (6 cases, 31.6%) CTSK expression.